Clinical Trial Detail

NCT ID NCT02576431
Title A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors (NAVIGATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

salivary gland cancer

biliary tract cancer

lung cancer

breast cancer

Advanced Solid Tumor

sarcoma

colorectal cancer

central nervous system cancer

lung non-small cell carcinoma

thyroid gland cancer

melanoma

Therapies

Larotrectinib

Age Groups: adult senior child

No variant requirements are available.